Duchenne Muscular Dystrophy Archives

TRiNDS and Italfarmaco Announce US Patient Advocacy Partnership for EPIDYS Trial of Givinostat for Duchenne Muscular Dystrophy

Pittsburgh, PA, November 9, 2018 - Therapeutic Research in Neuromuscular Disorders Solutions (TRiNDS), a specialty contract research organization, and Italfarmaco SpA, a privately held [...]

2024-07-17T15:08:15+02:002018 November 09|Tags: Duchenne Muscular Dystrophy, Italfarmaco|

Registered office and factory
ITALFARMACO S.p.A.
Viale Fulvio Testi, 330
20126 Milano
Tel. +39 02 64431
Fax +39 02 644346 / +39 02 66102753

Management, offices and research center
ITALFARMACO S.p.A.
Via dei Lavoratori, 54
20092 Cinisello Balsamo (MI)
Tel. +39 02 64431
Fax +39 02 6424790

Contacts
Career

TIN and VAT n. 00737420158